"Under the collaboration, STEMI India and AstraZeneca IndiaBSE 0.05 % will work together to emphasise the importance of the 'Golden Hour' and appropriate treatment strategies across the country for improving the standard of care for heart attack patients," AstraZeneca said in a statement said.
ndia has a high burden of Coronary Artery Disease (CAD) in the world; upwards of 3 million heart attacks occur in India every year.
No comments:
Post a Comment